Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Diarrhea × shosaiko-to × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Liver Neoplasms 1 Diarrhea 1 Carcinoma, Hepatocellular 1

Interventions

Irinotecan 4 Octreotide 3 Leucovorin 2 Fluorouracil 2 shosaiko-to 1 maltodextrin 1 lanreotide 1 isatuximab 1 bile acid binding proteins 1 Temozolomide 1 Sulfasalazine 1 Raloxifene Hydrochloride 1 Radiation 1 Probiotics 1 Oxaliplatin 1 Loperamide 1 Long-Term Synaptic Depression 1 Levofloxacin 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Diet Therapy 1 Cyclophosphamide 1 Colesevelam Hydrochloride 1 Celecoxib 1 Cefpodoxime 1 Cefixime 1 Calcium Aluminosilicate 1 Anti-Bacterial Agents 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Guangzhou University of Traditional Chinese Medicine

Phase NA Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡